TNFRSF14 levels showed a parallel modulation (Figure 3H), suggesting that inhibiting the BTLA‐TNFRSF14 pathway may protect against lung damage and reduce inflammation in BPD. The gene discussed is BTLA; the disease is bronchopulmonary dysplasia.